The Role and Therapeutic Targeting of CCR5 in Breast Cancer.

Cells · 2023 · PMC10526962 · PMID 37759462

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

In patients with ER-negative breast cancer receiving chemotherapy, patients with increased CCR5 populations showed a strong trend toward reduced metastasis-free and relapse-free survival compared with the patient population showing reduced CCR5 expression in their tumors [ 9 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.